Rare diseases
Investigational molecules
Locations
Zaloska Cesta 7, 1000 Ljubljana, Slovenia
University Medical Center Ljubljana in Ljubljana, Slovenia specialises in clinical trials of conditions such as Colitis ulcerative, Arteriosclerosis, Chronic inflammatory demyelinating polyradiculoneuropathy, Factor VIII deficiency, and other specialisations. This site conducts important research.
At University Medical Center Ljubljana, clinical research in Cardiovascular Diseases focuses on urgent bleeding management and improving care for patients who need surgery while taking anticoagulants. The studies are designed to evaluate whether new approaches can help control bleeding more effectively and support safer treatment decisions.
This work is especially relevant for people who require rapid, reliable bleeding control in high-risk surgical settings.
Research in Hemic and Lymphatic Diseases at the University Medical Center Ljubljana centers on Hemophilia A and Hemophilia B, with a strong focus on joint health and long-term disease management. The trials aim to better understand how prophylactic treatment may help preserve joint function and improve overall outcomes.
These studies support efforts to refine care for bleeding disorders and monitor how treatment may influence daily quality of life.
Clinical trials currently enrolling participants at this site.
SloveniaA Study Comparing Empasiprubart Versus Intravenous Immunoglobulin in Adults With Chronic Inflammatory Demyelinating Polyneuropathy
SloveniaA study to evaluate the safety of dazodalibep in patients with Sjögren's Syndrome over a long period of time
SloveniaA Study of Darovasertib Before Surgery or Radiation Therapy for Patients with Early-Stage Uveal Melanoma That Has Not Spread
SloveniaStudy on BI 690517 and Empagliflozin for Patients with Heart Failure and Preserved Ejection Fraction
SloveniaStudy of belumosudil versus drug combination in patients aged 12 years and older with chronic graft‑versus‑host disease refractory after prior therapy
SloveniaLong‑Term Safety Follow‑up of Ornithine Transcarbamylase Deficiency Patients Treated with ECUR‑506D and ECUR‑506A
SloveniaA study to evaluate the effectiveness of bleomycin sulfate for treating patients with low-flow vascular malformations using electrosclerotherapy.
SloveniaA study to evaluate the effectiveness and safety of remibrutinib in patients with secondary progressive multiple sclerosis
SloveniaA study to test if empasiprubart can improve function and is safe for adults with chronic inflammatory demyelinating polyneuropathy
SloveniaSloveniaA Study of Puxitatug Samrotecan Compared to Chemotherapy for Patients with Advanced Endometrial Cancer After Previous Platinum and Immunotherapy Treatment
SloveniaMove up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.
See the offer for sitesTell us about your condition – we search every trial in Europe and connect you with the right site.
